Acorda Therapeutics completes sales foce expansion

Share this article:
Acorda Therapeutics has completed the expansion of its sales force to 65 people, with 52 area business managers, calling on specialists and primary care physicians. The sales team promotes Zanaflex Capsules (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions